1. Home
  2. TPC vs CDTX Comparison

TPC vs CDTX Comparison

Compare TPC & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tutor Perini Corporation

TPC

Tutor Perini Corporation

HOLD

Current Price

$68.30

Market Cap

3.1B

ML Signal

HOLD

Logo Cidara Therapeutics Inc.

CDTX

Cidara Therapeutics Inc.

HOLD

Current Price

$219.76

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPC
CDTX
Founded
1894
2012
Country
United States
United States
Employees
N/A
N/A
Industry
General Bldg Contractors - Nonresidential Bldgs
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
TPC
CDTX
Price
$68.30
$219.76
Analyst Decision
Strong Buy
Buy
Analyst Count
3
13
Target Price
$82.00
$119.44
AVG Volume (30 Days)
540.3K
2.1M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
0.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,103,323,000.00
N/A
Revenue This Year
$24.11
N/A
Revenue Next Year
$11.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.22
N/A
52 Week Low
$18.34
$15.22
52 Week High
$77.00
$220.46

Technical Indicators

Market Signals
Indicator
TPC
CDTX
Relative Strength Index (RSI) 62.14 88.62
Support Level $58.11 $218.86
Resistance Level $63.60 $220.46
Average True Range (ATR) 2.62 2.38
MACD 0.70 5.08
Stochastic Oscillator 98.02 99.41

Price Performance

Historical Comparison
TPC
CDTX

About TPC Tutor Perini Corporation

Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically, it derives key revenue from the United States.

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Share on Social Networks: